MétaCan
Menu
Back to cohort
Record W4414147952 · doi:10.1136/ebm-2025-pod.9

009 Frequency of low-value cancer screening: a nationwide population-based study

2025· article· en· W4414147952 on OpenAlexaff
Vladimir Jolidon, B. van der Linden, Nicolas Rodondi, Stéphane Cullati, Arnaud Chioléro

Bibliographic record

Venuenot available
Typearticle
Languageen
FieldMedicine
TopicBiomedical Ethics and Regulation
Canadian institutionsMcGill University
Fundersnot available
KeywordsProstate cancer screeningGuidelineCancer screeningCancerTest (biology)Screening testMEDLINEProstate cancerHealth care

Abstract

fetched live from OpenAlex

Objectives Cancer screening is only recommended when the benefits of a screening test outweigh its harms at a reasonable cost. Evidence-based guideline recommendations produced by independent expert bodies are an important decision-making tool that should guide cancer screening practices. Screening outside of these recommendations is a form of low-value care that can lead to unnecessary harm including overdiagnosis. Our goal was to estimate the frequency of colorectal, breast, cervical, and prostate cancer screening outside of the recommended age guidelines in Switzerland. Method We undertook a secondary data analysis of the 2022 Swiss Health Survey, a random-sampled nationwide population-based cross-sectional survey of 21,930 (36.2% participation rate) Swiss residents aged 15 years and above. Survey participants underwent telephone interviews where they self-reported cancer screening use for breast, cervical, colorectal, and prostate cancer. Participants indicated whether they had undergone specified screening tests and, if they had, the reason (preventive or other) and timing of their most recent corresponding test. We calculated participants’ age at screening and classified participants as either having not undergone screening, undergone screening within United States Preventive Service Taskforce (USPSTF) A, B, and C grade and A and B grade recommendations, or undergone screening outside these recommendations, respectively. Results Cancer screening outside of USPSTF A, B, and C recommendations was observed among 40.2% of older adults 75 years old or more (75+), with a higher proportion among women (44.5%) than men (35.1%) within this age group. The proportion of adults aged 75+ who have been screened outside of A and B recommendations was 50.4% (women: 50.2%; men: 50.5%). Among adults aged 40–59, the proportions screened outside of A, B, and C recommendations were 12.3% and 20.9% for A and B recommendations. Among women aged 20–39 years, screening outside of recommendations was observed at 9.9% for both A, B, and C and A and B recommendations. Cervical and prostate cancer screening were the most frequently used outside of A, B, and C recommendations among adults aged 75+ (37.1% of women; 34.0% of men). Conclusions Cancer screening outside of evidence-based recommendations is highly common, especially among older adults. These low-value screening practices likely contribute to high rates of overdiagnosis and overtreatment of inconsequential cancers. Interventions aimed at de-implementing and deterring this form of low-value care urgently need to be developed to prevent overdiagnosis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.029
Threshold uncertainty score0.058

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.356
Teacher spread0.334 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same topicBiomedical Ethics and RegulationFrench-language works237,207